Skip to main content
evidena care

Safety

Cannabis compared with tobacco: lungs, heart and circulation

What smoking cannabis does to the lungs, heart and blood vessels, how it differs from tobacco and why the route of intake matters.

Key points

  • Regular cannabis smoking is associated with coughing, sputum and signs of chronic bronchitis. In studies, these symptoms receded after stopping.
  • A clear link to COPD or lung cancer has not so far been shown for light to moderate use. For heavy long-term use, the evidence is mixed.
  • In a US survey of over 430,000 adults, daily cannabis use was associated with higher odds of heart attack and stroke, even in people who had never smoked tobacco.
  • A large part of the lung risks is linked to combustion. That vaporising or intake by mouth spares the lungs is plausible but has been little studied.

Smoking cannabis harms the lungs, but in a different way from tobacco. Regular cannabis smoking more often leads to coughing, sputum and signs of chronic bronchitis. A clear link to COPD or an increased risk of lung cancer with light to moderate use has not so far been shown. A review concludes that the risks to the lungs are considerably smaller than with tobacco.1

For the heart and circulation, the picture is less reassuring. In large population studies, frequent cannabis use was associated with more heart attacks and strokes, even in people who had never smoked tobacco.5 Many of these risks depend on the route of intake. This article sets out what studies show and where their limits lie.

Cannabis and tobacco: what is in the smoke

Cannabis smoke contains many of the same substances as tobacco smoke, including carcinogenic substances. The differences lie mainly in quantity and pattern: cannabis is usually smoked less often than cigarettes, but is often inhaled more deeply and held for longer.1,2

An important confounding factor is mixed use. In Europe, cannabis is often smoked together with tobacco. Many studies therefore find it hard to separate which consequences come from cannabis and which from tobacco. The imaging study further below also names this as a limitation.3

Cannabis and the lungs: bronchitis, lung function, COPD

A review by Tashkin summarised research on the lungs. Regular cannabis smoking causes visible and microscopic damage to the large airways. It is associated with coughing, sputum and wheezing, that is, with symptoms of chronic bronchitis. These symptoms receded after stopping.1

Lung function itself was mostly not clearly impaired in people who smoked only cannabis, in cross-sectional and longitudinal studies. A clear link to chronic obstructive pulmonary disease (COPD) was therefore not established.1 The 2017 report of the US National Academies came to a similar conclusion: it found substantial evidence of an association between cannabis smoking and episodes of bronchitis and more frequent respiratory symptoms.4

The US cohort study CARDIA followed 5,115 young adults over 20 years. Tobacco smoking was linearly associated with poorer lung function. For cannabis, the association was different: occasional and low lifetime use was not associated with poorer lung function. With very heavy use, the curve levelled off or reversed; however, data for this group were limited.2

Emphysema and imaging: newer findings

A Canadian study compared CT scans of the lungs of 56 people who smoked cannabis with non-smokers and people who smoked only tobacco. Emphysema, that is, over-inflation with destruction of the air sacs, was found in 75% of the cannabis group and in 5% of non-smokers. Inflammatory changes in the airways were more common in the cannabis group than in both other groups.3

The study is small and retrospective. Many people in the cannabis group also smoked tobacco, and the experts did not always agree in their assessment of the images. The authors themselves therefore warn against drawing strong conclusions.3 It is also in tension with the older data on lung function. It remains unclear how much cannabis smoking alone changes the lungs in the long term.

Lung cancer: mixed evidence

Cannabis smoke contains carcinogenic substances. Well-designed epidemiological studies have so far found no increased risk of lung cancer or cancer of the upper airways for light or moderate use. For heavy, long-term use, the evidence is mixed.1 The National Academies also found no established association between cannabis smoking and lung cancer, but pointed to gaps in the data.4 In any case, smoking is not a risk-free route of intake.

Cannabis, heart and circulation: what studies show

THC acts directly on the circulation. In a controlled study, the heart rate rose within 30 minutes of inhalation and returned to normal after three to four hours.7 For healthy people, this is usually harmless. With heart disease, a fast pulse can put additional strain on the heart.

A study published in the Journal of the American Heart Association in 2024 analysed survey data from 434,104 adults in the USA. After taking tobacco use and other factors into account, daily cannabis use was associated with 25% higher odds of heart attack and 42% higher odds of stroke. In people who had never smoked tobacco, the figures were similar or higher. The more days per month cannabis was used, the higher the odds.5

A Canadian analysis of the same US survey among 18- to 44-year-olds found a previous heart attack more often in people with recent cannabis use: 1.3% compared with 0.8%. The association appeared with use more than four times a month and with smoking as the main route of intake.6

Both studies are cross-sectional studies with self-reported data. They show an association but do not prove that cannabis is the cause, and they do not record exactly which products and amounts were used.5,6 How THC can interact with medicines for high blood pressure is explained in the article Cannabis and blood pressure medication.

Vaporising instead of smoking: the principle

When vaporising, the plant material is heated but not burned. This produces fewer combustion products than smoking. In a small before-and-after study, 20 people with frequent use and respiratory symptoms switched to a vaporiser for a month. In the 12 who did not get a respiratory infection during this time, symptoms and some lung function values improved. The authors consider this preliminary and called for a randomised trial.8 Good long-term data on lung health are still lacking today.

Vaporising is not “weaker”: in the controlled study by Spindle and colleagues, vaporised cannabis at the same dose led to higher THC levels in the blood and stronger effects than smoked cannabis.7 The effect on pulse and circulation also remains, because it comes from THC, not from the smoke. For people with heart disease, changing the route of intake therefore does not solve this problem.

With cannabis medicines prescribed by a doctor, the doctor determines the preparation and route of intake. Smoking is not a usual form. The forms available are described in the article Dosage forms of medical cannabis.

How it works at evidena

Before cannabis therapy, the doctor asks about heart, vascular and lung diseases, tobacco use and your medicines. Also mention heart attack or stroke in your family. Whether therapy is an option, and in what form, is decided by the doctor after this assessment. If a prescription is issued, it must be filled at a pharmacy within one month. As a rule, the prescribed quantity covers one month, in justified cases at most three months of treatment.9 You can book appointments at https://portal.evidena.care/appointments, and ask questions via WhatsApp or at info@evidena.care. In case of chest pain, shortness of breath or signs of paralysis, call the emergency number 144 immediately. Other risks are summarised in the Safety section.

Conclusion

Regular cannabis smoking puts a strain on the airways, but in studies the consequences for the lungs appear considerably smaller than with tobacco. For the heart and circulation, large surveys show an association between frequent use and heart attack and stroke, independent of tobacco. If you have heart or lung problems, discuss this with your doctor before any therapy.

Frequently asked questions

Is smoking cannabis worse than cigarettes?

For the lungs, reviews found considerably smaller consequences with regular cannabis smoking than with tobacco, but more bronchitis symptoms. A direct comparison is difficult because many people smoke both.

Does cannabis increase the risk of heart attack?

In population studies, frequent use was associated with more heart attacks and strokes. The studies show an association, not a certain cause.

Is vaporising healthier than smoking?

When vaporising, the plant material is not burned, so fewer combustion products are produced. However, good long-term studies on lung health are lacking.

May I receive a cannabis medicine if I have heart disease?

Your doctor decides this after weighing things up. In any case, mention heart and vascular diseases before starting therapy.

Your situation is individual

Discuss your questions with a doctor.

Book a consultation

Sources

  1. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013;10(3):239-247. doi:10.1513/AnnalsATS.201212-127FR
  2. Pletcher MJ et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA. 2012;307(2):173-181. doi:10.1001/jama.2011.1961
  3. Murtha L et al. Chest CT Findings in Marijuana Smokers. Radiology. 2023;307(1):e212611. doi:10.1148/radiol.212611
  4. National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington DC: National Academies Press; 2017. doi:10.17226/24625
  5. Jeffers AM et al. Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024;13(5):e030178. doi:10.1161/JAHA.123.030178
  6. Ladha KS et al. Recent cannabis use and myocardial infarction in young adults: a cross-sectional study. CMAJ. 2021;193(35):E1377-E1384. doi:10.1503/cmaj.202392
  7. Spindle TR et al. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial. JAMA Netw Open. 2018;1(7):e184841. doi:10.1001/jamanetworkopen.2018.4841
  8. Van Dam NT, Earleywine M. Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. Int J Drug Policy. 2010;21(6):511-513. doi:10.1016/j.drugpo.2010.04.001
  9. Betäubungsmittelkontrollverordnung (BetmKV), SR 812.121.1, Art. 47, Stand am 23. Januar 2023, Fedlex (accessed 13 November 2026)

Written by evidena.care editorial team · Published 13 November 2026 · Reviewed 13 November 2026

This article is general information and does not replace medical advice. Whether cannabis therapy is an option for you is decided by a doctor in a personal consultation.